Red Lion Hotel Corporation Announces CFO Departure
DENVER, May 15, 2020 (GLOBE NEWSWIRE) — Red Lion Hotels Corporation (the “Company”) (NYSE: RLH), announced today that its current […]
REPEAT – ViraxClear Opens New Market for Distribution of Test Kits with Moroccan LOI
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, May 15, 2020 […]
StorageVault Reports 2020 First Quarter Results and Increases Dividend
TORONTO, May 15, 2020 (GLOBE NEWSWIRE) — STORAGEVAULT CANADA INC. (“StorageVault” or the “Corporation”) (SVI-TSX-V) reported the Corporation’s 2020 first […]
The Joint Corp. to Participate in the 17th Annual Craig-Hallum Institutional Investor Conference
SCOTTSDALE, Ariz., May 15, 2020 (GLOBE NEWSWIRE) — The Joint Corp. (NASDAQ: JYNT), a national operator, manager and franchisor of […]
Medigus Signed an Exclusive Agreement with Elbit Systems Land for the Distribution in Mexico of Pandemic Response Ventilators for COVID-19 Patients
OMER, Israel, May 15, 2020 (GLOBE NEWSWIRE) — Medigus Ltd. (NASDAQ:MDGS) (TASE:MDGS), a technology company developing minimally invasive tools and […]
BeiGene Announces Clinical and Preclinical Data to Be Presented at the 2020 American Association for Cancer Research (AACR) Virtual Annual Meeting II
CAMBRIDGE, Mass., and BEIJING, China, May 15, 2020 (GLOBE NEWSWIRE) — BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology […]
DraftKings Reports First Quarter 2020 Results
Revenue grew 30%, despite COVID-19Continued to drive customer engagement without major sportsBOSTON, May 15, 2020 (GLOBE NEWSWIRE) — DraftKings Inc. […]
Zentalis Pharmaceuticals Reports First Quarter 2020 Financial Results and Operational Update
Completed initial public offering of common stock, raising approximately $190.0 million in gross proceedsFourth oncology Investigational New Drug (IND) application […]
Precision BioSciences Reports First Quarter 2020 Financial Results and Provides Business Update
Dosed First Patient in Phase 1/2a Clinical Study of PBCAR20A in Relapsed/Refractory NHL, CLL, and SLLPBCAR0191 Phase 1/2a Trial is […]
Autolus Therapeutics to Present New Data on AUTO1 and AUTO3 at the 2020 EHA Annual Meeting
– Data builds on positive data presented at American Society of Hematology in December 2019 and EHA-EMBT 2nd European CAR T […]
